ABSTRACT

Liver transplantation (LT) is an acceptable mode of therapy for end-stage liver diseases of varying etiology. With the exception of certain disorders of genetic and toxic etiology, most other diseases can recur in the liver allograft. Hie recurrent diseases can share clinicopathological features of other graft disorders such as acute and chronic rejection and ischemic injury. Recurrent hepatitis C is a major problem in the post-LT period. The salient clinicopathological features of recurrent diseases are discussed.